Nuvation Bio
NUVB
NUVB
202 hedge funds and large institutions have $818M invested in Nuvation Bio in 2025 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 82 increasing their positions, 48 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
12% more funds holding
Funds holding: 181 → 202 (+21)
1.61% less ownership
Funds ownership: 66.04% → 64.43% (-1.6%)
Holders
202
Holding in Top 10
6
Calls
$7.64M
Puts
$3.87M
Top Buyers
| 1 | +$8.4M | |
| 2 | +$6.33M | |
| 3 | +$4.89M | |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$3.68M |
| 5 |
Two Sigma Investments
New York
|
+$3.17M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$9.01M | |
| 3 | -$8.8M | |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$6.03M |
| 5 |
BlackRock
New York
|
-$3.08M |
